ABEC

Boca Bearings Revolutionizes Industrial Machinery Performance with Cutting-Edge Machine Tool Bearings

Retrieved on: 
Saturday, March 9, 2024
ISO, ABEC, Maintenance (technical)

BOYNTON BEACH, Fla., March 9, 2024 /PRNewswire-PRWeb/ -- Machine Tool Bearings are an indispensable component of industrial machinery, and Boca Bearings is leading the charge in enhancing performance and reliability with their innovative solutions.

Key Points: 
  • Machine Tool Bearings are an indispensable component of industrial machinery, and Boca Bearings is leading the charge in enhancing performance and reliability with their innovative solutions.
  • BOYNTON BEACH, Fla., March 9, 2024 /PRNewswire-PRWeb/ -- Machine Tool Bearings are an indispensable component of industrial machinery, and Boca Bearings is leading the charge in enhancing performance and reliability with their innovative solutions.
  • "Its extensive range of Standard and Ceramic Hybrid Machine Tool Bearings sets Boca Bearings apart."
  • For more information on how Boca Bearings' Machine Tool Bearings can elevate the performance of industrial machinery, please visit their website at www.bocabearings.com or contact the customer service team at [email protected] .

Global Single Use Bioreactors Markets, 2023-2035 - Rising Interest in Large Scale Disposable Bioreactors for Single use Bioprocessing - ResearchAndMarkets.com

Retrieved on: 
Monday, October 23, 2023
Security, Health, Technology, Other Technology, Pharmaceutical, Biotechnology, Type, Water, USFDA, Merck Millipore, Pressure, Food and Bioprocess Technology, Compound, Merck, Growth, Cell culture, Eppendorf, Medicine, Risk, Thermo Fisher Scientific, Safety, CMOS, ABEC, Fine chemical, Sewage treatment, Bioreactor

Single use Bioreactor Market Size: Stirred Tank Single-Use Bioreactor Segment holds the Largest Market Share

Key Points: 
  • Single use Bioreactor Market Size: Stirred Tank Single-Use Bioreactor Segment holds the Largest Market Share
    The global single use bioreactors market is likely to be worth around USD 1.3 billion in 2023.
  • Currently, the global market for single-use bioreactors is dominated by companies providing stirred tank bioreactors.
  • The global market for single use bioreactors is anticipated to witness substantial growth during the forecast period.
  • It is worth highlighting that majority of the single use bioreactors (~60%) offered by various manufacturers are stirred tank bioreactors.

ABEC Introduces 5 Year Warranty for CSR® Single-Use Systems Products

Retrieved on: 
Tuesday, August 1, 2023
Biotechnology, Manufacturing, Other Manufacturing, Health, Engineering, Travel, Industrial fermentation, CSR, Bioreactor, Fine chemical, ABEC

ABEC , a leader in engineered solutions and services for biotech manufacturing, today announced a 5-year warranty for its Custom Single Run (CSR®) single-use systems products.

Key Points: 
  • ABEC , a leader in engineered solutions and services for biotech manufacturing, today announced a 5-year warranty for its Custom Single Run (CSR®) single-use systems products.
  • The 5-year warranty is unprecedented in the bioprocess systems industry and is effective immediately for all new purchases of CSR equipment.
  • Since its inception almost 50 years ago, ABEC has been renowned for the quality and reliability of its products.
  • It applies to all CSR products, including Bioreactors, Fermenters, General Mixers (GenMix), Large Volume Solutions Holders, and TFF Systems.

Eli Lilly Selects ABEC for World’s Largest Single-Use Biopharmaceutical Manufacturing Facility

Retrieved on: 
Monday, July 10, 2023
Biotechnology, Other Health, Health, Pharmaceutical, Health Technology, Heart, Bioreactor, CSR, Plant, Lilly, BOD, Engineering, Fine chemical, ABEC

ABEC , a leader in engineered solutions and services for biotech manufacturing, announced it will deliver multiple Custom Single Run (CSR®) single-use systems to Eli Lilly’s next-generation biopharmaceutical manufacturing facility in Limerick, Ireland.

Key Points: 
  • ABEC , a leader in engineered solutions and services for biotech manufacturing, announced it will deliver multiple Custom Single Run (CSR®) single-use systems to Eli Lilly’s next-generation biopharmaceutical manufacturing facility in Limerick, Ireland.
  • ABEC’s large-scale CSR Bioreactors will be at the heart of the facility, and ABEC will also manufacture, test, and install large-scale CSR GenMix systems.
  • Lilly selected ABEC to support Basis of Design (BOD) engineering of the facility’s upstream and downstream processes utilizing ABEC’s CSR technology.
  • “ABEC is proud to be partnering with Lilly on this important project,” said Scott Pickering, ABEC CEO and Chairman.

Global Single-use Bioreactors Market 2023 to 2030: Increasing Adoption of SUBs Among Small Companies and Startups Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, July 7, 2023
Biotechnology, Health, Other Manufacturing, Manufacturing, Serum Institute of India, Vaccine, Submarine, COVID-19, Growth, ABEC, Investment, Nature, Buffer, USD, Fine chemical

The global single-use bioreactors market size is expected to reach USD 12.06 billion by 2030, registering a CAGR of 17.19% from 2023 to 2030.

Key Points: 
  • The global single-use bioreactors market size is expected to reach USD 12.06 billion by 2030, registering a CAGR of 17.19% from 2023 to 2030.
  • Owing to the rising demand for biopharmaceuticals, coupled with increasing investments in single-use technologies, the market for single-use bioreactors is expected to witness significant growth throughout the forecast period.
  • The segment is being driven by the increasing usage of single-use bioreactors for mammalian cell culture in several research studies.
  • Factors such as rising investments and funding initiatives among Asian companies are expected to drive the market in the region.

WuXi Biologics Awarded an ISPE Facility of the Year Award in the Operations Category

Retrieved on: 
Wednesday, May 24, 2023
Other Manufacturing, Commercial Building & Real Estate, Construction & Property, Engineering, Building Systems, Manufacturing, Biotechnology, Architecture, Pharmaceutical, Health, Operation, PE, Therapy, Loo of the Year Awards, ISPE, ABEC, Perfusion, International Society of Sculptors, Painters and Gravers, Medication, Multimedia, COVID, Needle, United Nations Office for Project Services, Patient, WuXi Biologics, Artifact, IPS, Wuxi, Automation, Fine chemical

IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation ( EPCMV ) services, congratulates WuXi Biologics Ireland Limited (WuXi Biologics) for receiving a Facility of the Year Award (FOYA) from The International Society for Pharmaceutical Engineering (ISPE) in the Operations category for their Large-Scale Manufacturing Facility in Mullagharlin, Dundalk, Ireland.

Key Points: 
  • IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation ( EPCMV ) services, congratulates WuXi Biologics Ireland Limited (WuXi Biologics) for receiving a Facility of the Year Award (FOYA) from The International Society for Pharmaceutical Engineering (ISPE) in the Operations category for their Large-Scale Manufacturing Facility in Mullagharlin, Dundalk, Ireland.
  • View the full release here: https://www.businesswire.com/news/home/20230518005360/en/
    WuXi Biologics' Large-Scale Manufacturing Facility in Mullagharlin, Dundalk, Ireland.
  • WuXi Biologics was recognized for its cutting-edge biologics manufacturing facility in Dundalk, Ireland.
  • Congratulations to WuXi Biologics on this incredible achievement,“ said Dave Goswami, PE, IPS Chairman and Chief Executive Officer.

GOOD Meat Receives Approval to Commercialize Serum-Free Media

Retrieved on: 
Wednesday, January 18, 2023
Restaurant, Bar, Food, Beverage, Agriculture, Natural Resources, Retail, Animal, Ecosystem, News, Meat, Food technology, Cell, Singapore Food Agency, Eat Just, Poultry, Seafood, Bioreactor, GOOD, ABEC, Health, Partnership, The Singapore Economic Review, Research, Serum, SFA, The Good Food Institute, Multimedia, Table, Food security

GOOD Meat , the cultivated meat division of food technology company Eat Just, Inc., announced today that it has been given a new, first-in-the-world regulatory approval by the Singapore Food Agency (SFA) for the use of serum-free media for the production of cultivated meat.

Key Points: 
  • GOOD Meat , the cultivated meat division of food technology company Eat Just, Inc., announced today that it has been given a new, first-in-the-world regulatory approval by the Singapore Food Agency (SFA) for the use of serum-free media for the production of cultivated meat.
  • View the full release here: https://www.businesswire.com/news/home/20230117006210/en/
    GOOD Meat R&D team members working at the company's cultivated meat facility (Photo: Eat Just, Inc.)
    GOOD Meat obtained approval from SFA for its first chicken product in November 2020 and a subsequent approval for new formats of its pioneering poultry in November 2021.
  • I could not be prouder of our team for doing just that and receiving approval to commercialize it this week.
  • “We congratulate GOOD Meat on achieving this milestone in scaling up cultivated meat production.

Microbial Fermentation Technology Market Trends/Analysis Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Friday, December 16, 2022
Biotechnology, Pharmaceutical, Health, Genomatica, Metabolic engineering, SUB, National Biotechnology Research Park, Cargill, CSR, ABEC, CMOS, Cyclone, Agitation, Inactivated vaccine, Tropical cyclone engineering, SWOT, Fermentation, USD, Growth, Biopharmaceutical, Hormone, Fine chemical, Vaccine

The "Microbial Fermentation Technology Market Size, Share & Trends Analysis Report by Application (Antibiotics, Vaccines), by End-use (Biopharmaceutical Companies), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Microbial Fermentation Technology Market Size, Share & Trends Analysis Report by Application (Antibiotics, Vaccines), by End-use (Biopharmaceutical Companies), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • Since fermentation is observed to be of utmost importance in the manufacturing of biopharmaceuticals, there is also a growing demand for microbial fermentation technology in biopharmaceutical manufacturing.
  • The newly installed solutions are expected to provide a faster turnaround time with high-growth microbial fermentation on large scale.
  • Furthermore, technological advances in microbial fermentation platforms are also expected to supplement the market growth.

Yvolution introduces Innovative and Popular Line of Fliker Pro's and Twista Skates To The United States

Retrieved on: 
Wednesday, October 5, 2022
CA, Skiing, Motion, ABEC, Technology, FLEX, Go-kart, Yossi Fliker, Patent, Walmart, Amazon, Life, Child, Heel, Sensation, Toy

LOS ANGELES, Oct. 5, 2022 /PRNewswire/ -- Yvolution, known for their innovative award-winning scooters, balance bikes and flikers is excited to announce two new additions to the lineup, The Fliker Pro and Twista Skates! These new products are designed with kids in mind. Both have innovative designs to not only keep your kids safe, but to grow with them as well.

Key Points: 
  • Both have innovative designs to not only keep your kids safe, but to grow with them as well.
  • Popular in Europe, The Fliker is the most recognizable from the Yvolution fleet but now they are launching the Fliker Pro.
  • Flexing footplates connect the body with Fliker Pro through the feet, resulting in outstanding control and extreme speed.
  • The rest of the Fliker has been redesigned from the ground up, making small improvements to an already great performing FLIKER platform.

Single-use Bioprocessing Market Research - Global Opportunity Analysis and Industry Forecasts, 2020-2021 & 2022-2030 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 5, 2022
Health, Manufacturing, Other Health, Other Manufacturing, Pharmaceutical, Biotechnology, Method, COVID-19, CMOS, Lists of diseases, Filtration, Technology, Application, Vaccine, Mab, ABEC, Serum Institute of India, China Biologic Products, Bioreactor, Therapy, CAGR, SUT, Single, Growth, CSR, Adoption, Biomanufacturing, Coal, Fine chemical, Novavax

The "Single-use Bioprocessing Market By Product, By Application, By Method, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Single-use Bioprocessing Market By Product, By Application, By Method, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
  • Rise in the adoption of single-use technologies, lower risk of product cross-contamination, and less floor space requirements drive the single-use bioprocessing market.
  • In addition, single-use bioprocessing technologies are highly efficient and cost-effective, which attract pharmaceutical manufacturers to adopt disposable bioprocessing products, thus propelling the demand for single-use bioprocessing technologies.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global single-use bioprocessing market growth.